Anticancer Potential of Cannabidiol in Renal Cell Carcinoma: Serum Modulation and Preliminary Mechanistic Insights.
This study explores the anticancer potential cannabidiol renal cell carcinoma effects through serum modulation. Preliminary mechanistic insights provide a foundation for further research. The findings highlight the need for cautious interpretation in…
Cannabinoids Show Modest Promise for Cancer-Related Appetite Loss in Older Adults, But Evidence Remains Thin
Cannabinoid receptor type 1 activation plays a role in appetite regulation for older adults with cancer-related anorexia. Current evidence shows modest benefits but remains limited and inconclusive. Further research is needed to establish clinical…
Targeting Molecular Pathways in Neuropathic Cancer Pain: From Mechanisms to Novel Therapeutics
Neuropathic cancer pain management remains a significant clinical challenge due to its complex molecular pathways. Emerging therapeutics targeting these pathways offer new hope for relief. This review highlights advances in neuropathic cancer pain…
Hemp Seed Extract Modulates Metabolic Stress and Autophagy in Cancer Cells
Hemp seed extract anticancer effects involve metabolic stress that reduces ATP and activates AMPK pathways. This extract induces cytostatic effects by arresting cancer cell growth. Autophagy modulation enhances these anticancer effects, offering new…
Exploring CBD as a Prophylactic Agent Against Glioblastoma Growth
This CBD glioblastoma preclinical study examines cannabidiol's potential to reduce tumor growth in glioblastoma. The research shows prolonged CBD exposure may modulate immune and tumor markers. While promising, these findings are preliminary and require…
Demographics, methods of use, and perceived benefits among patients with cancer who use cannabis.
This study examines demographics cannabis use cancer patients, focusing on reasons, methods, and perceived benefits. Nearly 25% of surveyed cancer patients reported cannabis use. The findings provide insight into patient behaviors and symptom management.
The Canadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview
The CAN-PACT program focuses on psychedelic-assisted therapy cancer patients to address demoralization syndrome. This multi-phase initiative aims to improve supportive care for advanced cancer patients. It establishes clinical infrastructure and training…
Cannabidiol Drug Interactions: Clinical Evidence Review
Cannabidiol drug interactions clinical evidence highlights CBD's potential to interact with multiple drug classes, especially opioids. Careful medication review is essential before starting CBD in patients on complex regimens. Clinicians should treat CBD…
Australian Trial to Test Medicinal Cannabis Against Chemotherapy’s Gut Side Effects
Cannabinoid clinical trials for chemotherapy mucositis are underway to evaluate CBD/THC's potential in preventing gastrointestinal side effects. This phase II trial tests sublingual wafers in adults receiving mucotoxic chemotherapy. Results are pending,…
Australian Trial to Test Whether Cannabis Can Prevent Chemotherapy Gut Damage: Protocol Published
The cannabis chemotherapy mucositis trial is the first rigorous study testing combined CBD and THC to prevent chemotherapy-induced gut damage. This protocol outlines the design of a phase II randomized controlled trial focused on gastrointestinal…
